Do statin drugs decrease progression to cirrhosis in HIV/hepatitis C virus coinfected individuals?
Statin drug use is beneficial in mitigating the risk of liver disease progression for HIV/HCV coinfected patients without advanced liver disease. Low HDL and diabetes in coinfected patients with abnormal ALT have greater risk of cirrhosis development.
Determination of leptin levels might provide useful predictive information for lung cancer.